Coverart for item
The Resource Biomaterial control of therapeutic stem cells, by Akon Higuchi

Biomaterial control of therapeutic stem cells, by Akon Higuchi

Label
Biomaterial control of therapeutic stem cells
Title
Biomaterial control of therapeutic stem cells
Statement of responsibility
by Akon Higuchi
Creator
Author
Subject
Language
eng
Summary
Using this book, the reader will gain a robust overview of current research and a clearer understanding of the status of clinical trials for stem cell therapies
Member of
Cataloging source
N$T
http://library.link/vocab/creatorDate
1956-
http://library.link/vocab/creatorName
Higuchi, Akon
Dewey number
616.02774
Index
index present
LC call number
QH588.S83
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
Series statement
Biomaterials science series
Series volume
4
http://library.link/vocab/subjectName
  • Stem cells
  • Biomedical materials.
  • Stem Cell Transplantation
  • Stem Cells
  • Regenerative Medicine
  • Biocompatible Materials
  • Tissue Engineering
  • Organ Culture Techniques
Label
Biomaterial control of therapeutic stem cells, by Akon Higuchi
Instantiates
Publication
Copyright
Antecedent source
unknown
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • 1.1 Introduction -- 1.2 Stem Cells -- 1.3 The Extracellular Matrix -- 1.4 hPSC Culture on Biomaterials -- 1.5 hPSC Differentiation on Biomaterials -- 1.6 Biomaterials Control hPS Cell Differentiation Fate -- 1.7 Stem Cell Therapy Using Biomaterials -- References -- Chapter 2. Adult Stem Cell Culture on Extracellular Matrices and Natural Biopolymers -- 2.1 Introduction -- 2.2 Chemical and Biological Interactions of ECM Proteins and Stem Cells -- 2.3 Collagen -- 2.3.1 Collagen Type I Scaffold -- 2.3.2 Organic Hybrid Scaffold Made of Collagen Type I2.3.3 Scaffolds Using Collagen Type II and Type III -- 2.3.4 Hybrid Collagen Scaffold Using Inorganic Materials -- 2.3.5 Collagen Scaffolds Immobilized Antibody Targeting Stem Cells -- 2.3.6 Differentiation into Endoderm and Ectoderm Lineages Using Collagen Scaffolds -- 2.4 Gelatin -- 2.4.1 Gelatin Hydrogels and Scaffolds -- 2.4.2 Gelatin Hybrid Scaffolds -- 2.5 Laminin -- 2.6 Fibronectin -- 2.7 Vitronectin -- 2.8 Fibrin -- 2.9 Decellularized ECM -- 2.10 Biomaterials with ECM-mimicking Oligopeptides -- 2.10.1 MS Cell Differentiation on Self-assembled ECM-peptide Nanofibers2.10.2 Osteogenic Induction on ECM-peptide Immobilized Dishes and Scaffolds -- 2.10.3 Chondrogenic Induction on ECM-peptide Immobilized Dishes and Scaffolds -- 2.10.4 Neural Induction on ECM-peptide Immobilized Dishes and Scaffolds -- 2.11 Biomaterials with N-Cadherin Mimicking Oligopeptides -- 2.12 Conclusion and Future Perspective -- References --
  • Chapter 3. Feeder-free and Xeno-free Culture of Human Pluripotent Stem Cells on Biomaterials -- 3.1 Introduction -- 3.2 Analysis of the Pluripotency of hPS Cells -- 3.3 2D Cultivation of hPS Cells on Biomaterials3.3.1 hPS Cell Cultivation on ECM-immobilized Surfaces in 2D -- 3.3.2 hPS Cell Cultivation on Oligopeptide-immobilized Surfaces in 2D -- 3.3.3 hPS Cell Cultivation on a Recombinant E-cadherin Surface in 2D -- 3.3.4 hPS Cell Cultivation on Biomaterials Immobilized with Polysaccharide in 2D -- 3.3.5 hPS Cell Cultivation on Synthetic Biomaterials in 2D -- 3.4 Three-dimensional Cultivation of hPS Cells on Biomaterials -- 3.4.1 The 3D Cultivation of hPS Cells on Microcarriers -- 3.4.2 The 3D Cultivation of hPS Cells Embedded in Hydrogels (Microcapsules) -- 3.5 hPS Cell Cultivation on PDL-coated Dishes with Small Molecules3.6 Conclusion and Future Perspectives -- Acknowledgements -- References -- Chapter 4. Differentiation Fates of Human ES and iPS Cells Guided by Physical Cues of Biomaterials -- 4.1 Introduction -- 4.2 Induction Protocols of Human Pluripotent Stem Cells -- 4.2.1 EB Formation -- 4.2.2 Induction of hPS Cells by EB Generation -- 4.2.3 Induction of hPS Cells Seeded on Materials Directly -- 4.3 Physical Cues of Materials in hPS Cell Induction -- 4.3.1 Effect of Elasticity of Cell Cultivation Biomaterials on Stem Cell Induction -- .3.2 Topographic Effects of Biomaterials on the Differentiation Fates of hPS Cells -- 4.3.3 Stem Cell Induction on Nanofibers -- 4.3.4 Effect of Electrical and Mechanical -- Forces of Biomaterials on Induction Fate of hPS Cells -- 4.4 Conclusions and Perspectives -- References --
  • Chapter 5. Biomaterial Control of Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells -- 5.1 Introduction -- 5.2 Induction of hPS Cells into Neural Lineages -- 5.2.1 Stromal-induced Differentiation into Neural Lineages -- 5.2.2 Induction into Neural Lineages Through EB Generation -- 5.2.3 Direct Induction into Neural Lineages on Materials with No EB Generation -- 5.2.4 Effect of Cell Cultivation Materials on hPS Cell Induction into Neural Lineages -- 5.3 Induction of hPS Cells into Cardiomyocytes -- 5.3.1 Efficient Protocols for Inducing hPS -- Cells into Cardiomyocyte -- 5.3.2 Effect of Cell Cultivation Materials on hPS Cell Induction into Cardiomyocytes -- 5.4 Induction into Hepatocytes -- 5.4.1 Efficient Protocols for hPS Cell Induction into Hepatocytes on Materials -- 5.4.2 3D Cultivation Facilitates the Induction of hPS Cells into Hepatocytes -- 5.4.3 Effect of Cell Culture Biomaterials on hPS Cell Differentiation into Hepatocytes -- 5.5 Differentiation into Insulin-secreting b Cells -- 5.6 Conclusions and Perspectives -- References --
  • Chapter 6. Clinical Trials of Stem Cell Therapies Using Biomaterials -- 6.1 Introduction -- 6.2 Stem Cell Therapy for Myocardial Infarction (MI) in Clinical Trials -- 6.2.1 Clinical Therapies for MI Using hES cells -- 6.2.2 Clinical Therapy for MI Using Fetal and Adult Stem Cells -- 6.2.3 Future Trends of MI Therapy Using Stem Cells -- 6.3 Stem Cell Therapy for Macular Degeneration Disease in Clinical Trials -- 6.3.1 Macular Degeneration Diseases and Eye Structure -- 6.3.2 Bioengineering in Stem Cell Therapies for Macular Degeneration Diseases -- 6.3.3 Biomaterial Assists in the Therapies for Macular Degeneration Diseases -- 6.3.4 Bioengineering for Clinical Trials Using hES Cell-derived RPE Cells -- 6.3.5 Bioengineering for Clinical Trials Using hiPS Cell-derived RPE Sheets -- 6.3.6 Bioengineering for Clinical Trials Using Adult Stem Cells -- 6.3.7 Clinical Trials Using Fetal Stem Cells -- 6.3.8 Future Perspectives of Stem Cell Therapy for Macular Degeneration Diseases -- References -- Chapter 7. Conclusions and Future Perspective on Biomaterial Control of Therapeutic Stem Cells
Dimensions
unknown
Extent
1 online resource.
File format
unknown
Form of item
online
Isbn
9781788012072
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
c
http://library.link/vocab/ext/overdrive/overdriveId
5029:4881
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
  • on1088436854
  • (OCoLC)1088436854
Label
Biomaterial control of therapeutic stem cells, by Akon Higuchi
Publication
Copyright
Antecedent source
unknown
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Contents
  • 1.1 Introduction -- 1.2 Stem Cells -- 1.3 The Extracellular Matrix -- 1.4 hPSC Culture on Biomaterials -- 1.5 hPSC Differentiation on Biomaterials -- 1.6 Biomaterials Control hPS Cell Differentiation Fate -- 1.7 Stem Cell Therapy Using Biomaterials -- References -- Chapter 2. Adult Stem Cell Culture on Extracellular Matrices and Natural Biopolymers -- 2.1 Introduction -- 2.2 Chemical and Biological Interactions of ECM Proteins and Stem Cells -- 2.3 Collagen -- 2.3.1 Collagen Type I Scaffold -- 2.3.2 Organic Hybrid Scaffold Made of Collagen Type I2.3.3 Scaffolds Using Collagen Type II and Type III -- 2.3.4 Hybrid Collagen Scaffold Using Inorganic Materials -- 2.3.5 Collagen Scaffolds Immobilized Antibody Targeting Stem Cells -- 2.3.6 Differentiation into Endoderm and Ectoderm Lineages Using Collagen Scaffolds -- 2.4 Gelatin -- 2.4.1 Gelatin Hydrogels and Scaffolds -- 2.4.2 Gelatin Hybrid Scaffolds -- 2.5 Laminin -- 2.6 Fibronectin -- 2.7 Vitronectin -- 2.8 Fibrin -- 2.9 Decellularized ECM -- 2.10 Biomaterials with ECM-mimicking Oligopeptides -- 2.10.1 MS Cell Differentiation on Self-assembled ECM-peptide Nanofibers2.10.2 Osteogenic Induction on ECM-peptide Immobilized Dishes and Scaffolds -- 2.10.3 Chondrogenic Induction on ECM-peptide Immobilized Dishes and Scaffolds -- 2.10.4 Neural Induction on ECM-peptide Immobilized Dishes and Scaffolds -- 2.11 Biomaterials with N-Cadherin Mimicking Oligopeptides -- 2.12 Conclusion and Future Perspective -- References --
  • Chapter 3. Feeder-free and Xeno-free Culture of Human Pluripotent Stem Cells on Biomaterials -- 3.1 Introduction -- 3.2 Analysis of the Pluripotency of hPS Cells -- 3.3 2D Cultivation of hPS Cells on Biomaterials3.3.1 hPS Cell Cultivation on ECM-immobilized Surfaces in 2D -- 3.3.2 hPS Cell Cultivation on Oligopeptide-immobilized Surfaces in 2D -- 3.3.3 hPS Cell Cultivation on a Recombinant E-cadherin Surface in 2D -- 3.3.4 hPS Cell Cultivation on Biomaterials Immobilized with Polysaccharide in 2D -- 3.3.5 hPS Cell Cultivation on Synthetic Biomaterials in 2D -- 3.4 Three-dimensional Cultivation of hPS Cells on Biomaterials -- 3.4.1 The 3D Cultivation of hPS Cells on Microcarriers -- 3.4.2 The 3D Cultivation of hPS Cells Embedded in Hydrogels (Microcapsules) -- 3.5 hPS Cell Cultivation on PDL-coated Dishes with Small Molecules3.6 Conclusion and Future Perspectives -- Acknowledgements -- References -- Chapter 4. Differentiation Fates of Human ES and iPS Cells Guided by Physical Cues of Biomaterials -- 4.1 Introduction -- 4.2 Induction Protocols of Human Pluripotent Stem Cells -- 4.2.1 EB Formation -- 4.2.2 Induction of hPS Cells by EB Generation -- 4.2.3 Induction of hPS Cells Seeded on Materials Directly -- 4.3 Physical Cues of Materials in hPS Cell Induction -- 4.3.1 Effect of Elasticity of Cell Cultivation Biomaterials on Stem Cell Induction -- .3.2 Topographic Effects of Biomaterials on the Differentiation Fates of hPS Cells -- 4.3.3 Stem Cell Induction on Nanofibers -- 4.3.4 Effect of Electrical and Mechanical -- Forces of Biomaterials on Induction Fate of hPS Cells -- 4.4 Conclusions and Perspectives -- References --
  • Chapter 5. Biomaterial Control of Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells -- 5.1 Introduction -- 5.2 Induction of hPS Cells into Neural Lineages -- 5.2.1 Stromal-induced Differentiation into Neural Lineages -- 5.2.2 Induction into Neural Lineages Through EB Generation -- 5.2.3 Direct Induction into Neural Lineages on Materials with No EB Generation -- 5.2.4 Effect of Cell Cultivation Materials on hPS Cell Induction into Neural Lineages -- 5.3 Induction of hPS Cells into Cardiomyocytes -- 5.3.1 Efficient Protocols for Inducing hPS -- Cells into Cardiomyocyte -- 5.3.2 Effect of Cell Cultivation Materials on hPS Cell Induction into Cardiomyocytes -- 5.4 Induction into Hepatocytes -- 5.4.1 Efficient Protocols for hPS Cell Induction into Hepatocytes on Materials -- 5.4.2 3D Cultivation Facilitates the Induction of hPS Cells into Hepatocytes -- 5.4.3 Effect of Cell Culture Biomaterials on hPS Cell Differentiation into Hepatocytes -- 5.5 Differentiation into Insulin-secreting b Cells -- 5.6 Conclusions and Perspectives -- References --
  • Chapter 6. Clinical Trials of Stem Cell Therapies Using Biomaterials -- 6.1 Introduction -- 6.2 Stem Cell Therapy for Myocardial Infarction (MI) in Clinical Trials -- 6.2.1 Clinical Therapies for MI Using hES cells -- 6.2.2 Clinical Therapy for MI Using Fetal and Adult Stem Cells -- 6.2.3 Future Trends of MI Therapy Using Stem Cells -- 6.3 Stem Cell Therapy for Macular Degeneration Disease in Clinical Trials -- 6.3.1 Macular Degeneration Diseases and Eye Structure -- 6.3.2 Bioengineering in Stem Cell Therapies for Macular Degeneration Diseases -- 6.3.3 Biomaterial Assists in the Therapies for Macular Degeneration Diseases -- 6.3.4 Bioengineering for Clinical Trials Using hES Cell-derived RPE Cells -- 6.3.5 Bioengineering for Clinical Trials Using hiPS Cell-derived RPE Sheets -- 6.3.6 Bioengineering for Clinical Trials Using Adult Stem Cells -- 6.3.7 Clinical Trials Using Fetal Stem Cells -- 6.3.8 Future Perspectives of Stem Cell Therapy for Macular Degeneration Diseases -- References -- Chapter 7. Conclusions and Future Perspective on Biomaterial Control of Therapeutic Stem Cells
Dimensions
unknown
Extent
1 online resource.
File format
unknown
Form of item
online
Isbn
9781788012072
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
c
http://library.link/vocab/ext/overdrive/overdriveId
5029:4881
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
  • on1088436854
  • (OCoLC)1088436854

Library Locations

Processing Feedback ...